Explore the latest in tuberculosis, including recent advances in screening, prevention, diagnosis, treatment, and global control.
This systematic review and meta-analysis examines the safety and efficacy of bacillus Calmette-Guérin vaccination at birth or later points in infants who are preterm and/or had low birth weights compared with ones who are full term and/or had normal birth weights.
This randomized clinical trial evaluates the efficacy and safety of fludrocortisone in the treatment of cerebral salt wasting in patients with tuberculous meningitis.
This nested case-control study analyzes 3 independent cohorts to determine whether the 3-gene tuberculosis (TB) score can be a diagnostic tool throughout the course of TB disease and posttreatment residual inflammation by distinguishing individuals who progress to active TB vs those who do not, those with vs without active TB, and those with slower treatment response.
In this Viewpoint, Anthony Fauci summarizes the National Institute of Allergy and Infectious Diseases’ (NIAID’s) 2018 Strategic Plan for Tuberculosis (TB), which comprises investments in development of point-of-care diagnostics, vaccines, shorter-duration therapeutics, and infrastructure for systems biology and “omics” approaches to the infection.
This cohort study evaluates the association of implementation of a molecular testing strategy with length of isolation for patients with possible tuberculosis in a US hospital.
This randomized clinical trial tests the safety and efficacy of daily vs intermittent antituberculosis therapy in HIV-positive patients.
This cohort simulation model evaluates the use of tests and treatment of latent tuberculosis infection in residents born outside the United States.
This international cohort study examines the clinical features of tubercular uveitis and the associations with response to antitubercular therapy.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: